Dr. Helmut Schuehsler
Dr. Schuehsler started biotech investing in Germany in 1990, and made TVM Capital the leading and largest life science investor in Germany, led the development of the firm into one of the leading pan-European investors and started the life science activities in the Boston office. Starting in 2007, he spearheaded the creation of TVM Capital Healthcare which has investment teams in Singapore and Dubai, as well as representative offices in Munich and Boston. Dr. Schuehsler has been the deal leader on more than 35 direct investments in life science and healthcare companies in Europe, the U.S., the Middle East and India. In total he has raised more than US$1bn in committed capital from more than 50 international investors, has overseen more than 120 investments in the health market, and more than 50 IPOs and 30 M&A exit transactions in the portfolio.